Pfizer and Sangamo initiate dosing in Phase III haemophilia A trial
Haemophilia results in deficiency of a protein needed for blood clotting. Credit: allinonemovie from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more